Antibiotic resistance represents a threat to public health, and uncomplicated urinary tract infections (uUTIs) are an example of this concern. This systematic review (PROSPERO ID: CRD42020156674) is the first to determine the prevalence of E. coli resistance to fluoroquinolones in women with community-acquired uUTI. PubMed and Embase searches were conducted, 38 studies fulfilled eligibility criteria and were included in the systematic review. Within Europe, ciprofloxacin resistance in E. coli isolates varied between countries, and increased in some between 2006–8 and 2014–16, specifically in the UK (0.5% to 15.3%), Germany (8.7% to 15.1%), and Spain (22.9% to 30.8%), although methodologies and settings were often not comparable. In Asia there was a substantial increase in ciprofloxacin resistance during 2008–14 from 25% to more than 40%. In North America, resistance to ciprofloxacin also increased between 2008–2017, from 4% to 12%. Data exploring different age groups did not show a consistent relationship with resistance, whereas two studies found that fluoroquinolone resistance was higher in postmenopausal women than premenopausal women. One study indicated a link between fluoroquinolone resistance and uUTI recurrence. These findings may have implications for empirical treatment of uUTI with fluoroquinolones globally, but more data are needed to fully understand regional situations and impact on patient management.